Exacerbation of psoriasis in a chronic myelogenous leukemia patient treated with imatinib

J Dermatol. 2007 Oct;34(10):724-6. doi: 10.1111/j.1346-8138.2007.00369.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Benzamides
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Middle Aged
  • Piperazines / administration & dosage
  • Piperazines / adverse effects*
  • Psoriasis / chemically induced*
  • Psoriasis / pathology
  • Pyrimidines / administration & dosage
  • Pyrimidines / adverse effects*
  • Skin / pathology

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate